Pennsylvania Department of Health Bans Vaporized Medical Cannabis Products Containing Non-FDA Approved Ingredients
Capjah | Adobe Stock

Pennsylvania Department of Health Bans Vaporized Medical Cannabis Products Containing Non-FDA Approved Ingredients

The department lists more than 600 products on its website that are affected by the ban.

February 7, 2022

The Pennsylvania Department of Health’s Office of Medical Marijuana is banning vaporized medical cannabis products containing ingredients that have not been approved by the U.S. Food and Drug Administration (FDA), according to a local PAhomepage.com report.

The department recently completed a months-long review of vape products that resulted in a sprawling mandatory recall.

RELATED: Hundreds of Vape Products Recalled From Pennsylvania’s Medical Cannabis Market

State officials notified the state’s patients and caregivers of the recall Feb. 4.

“As you know, the Department recently conducted a statewide review of all vaporized medical marijuana products containing added ingredients,” the Department of Health wrote in the notice. “After finishing this review, the Department has determined that certain vaporized medical marijuana products containing some added ingredients have not been approved for inhalation by the United States Food and Drug Administration (FDA).

“Although some of these added ingredients may be considered safe in other non-inhaled products, patient safety is the top priority of the Medical Marijuana Program. Therefore, the department has issued a mandatory recall for all affected vaporized products.”

Now, state officials are going a step further and banning the use of products containing these non-FDA approved ingredients.

The lists of affected additives and products can be found on the department’s website.